PEAR

Pear Therapeutics, Inc. (PEAR) | Rumor.io

Pear Therapeutics

PEAR

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about PEAR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% new	0% new	0% 0

Apr 18

Pear Therapeutics' stock price has been held back and beaten down, with a volume spike before close, potentially indicating a short covering opportunity.
The company's CEO may be faking bankruptcy to sell off the company at shareholders' expense, but this would need to be clarified in a press release by tomorrow.
The stock's MACD histogram has turned positive, indicating a potential uptrend, and the company's initial VWAP rejection may lead to a retest.

Generated by AI

Sentiment

Of the messages about PEAR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	75% -20.57
Bearish	—	—	—	25% +20.57

Apr 14

$PEAR has the potential for a huge bounce, with some users expecting a 400% upside.
The asset has been increasing in volume, with a record-breaking daily growth of 2,081% of the 65-Day Volume Moving Average.
$PEAR is likely to experience a run-up on Fridays, with some users expecting a significant price increase due to the asset's delisting on the 19th.

Generated by AI

Topics

Of the messages about PEAR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	—	—
Announcements	—	—	—	—
Controversies	—	—	—	—
Earnings	—	—	—	—
Macro	—	—	—	—
Technical Analysis	—	—	—	—

Mar 18

Pear Therapeutics, Inc. ($PEAR) has started exploring "strategic alternatives" to address its financial challenges, including a potential merger and acquisition or licensing agreement.
The company is looking to bolster its financial situation, which may involve a change in ownership or a partnership with another company in the biotech or healthcare sector.
The announcement comes as Pear Therapeutics continues to navigate its financial challenges, with the company seeking to capitalize on new opportunities to drive growth and stability.

Generated by AI

Community

Of the messages about PEAR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	0%	0%	0%	0%
Newcomers	100%	100%	100%	100%

Regulars· Apr 18

$PEAR's MACD Histogram has turned positive, indicating a potential uptrend.
The Moving Average Convergence Divergence (MACD) indicator is a key momentum metric used to gauge trends.
Regulars are viewing odds for this indicator and others to gauge the stock's potential.

Newcomers· Apr 18

Newcomers are watching $PEAR for a potential price movement before it delists on Wednesday, speculating about the 20MA crossing over 50MA and 200MA, and wondering if shorts will cover.
Newcomers are concerned that the CEO of $PEAR may be faking a bankruptcy to sell off the company at the expense of shareholders.
Newcomers are analyzing the initial VWAP rejection of $PEAR and wondering if a last-minute buyout is in the works, also questioning the need for a clarification by the company in a press release.

Generated by AI

Also Discussed

Investors talking about PEAR also mention

#	Name	Attention
1	ELEV - Elevation Oncology, Inc.	——
2	HERA - FTAC Hera Acquisition Corp.	——
3	Mixed Martial Arts Group Ltd.MMA	0.02%new
4	Dover CorporationDOV	0%0
5	BOXD - Boxed, Inc.	——
6	Ensysce Biosciences, Inc. Common StockENSC	0%0
7	OSH - Oak Street Health, Inc.	——
8	Viatris Inc.VTRS	0%0
9	WETG - WeTrade Group, Inc.	——
10	Rafael Holdings Inc.RFL	0%0